Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Laboratorio Farmaceutico Erfo SpA's Revenue for the
six
months ended in Dec. 2025 was €4.66 Mil. Laboratorio Farmaceutico Erfo SpA's average Accounts Receivable for the
six
months ended in Dec. 2025 was €1.15 Mil.
Hence, Laboratorio Farmaceutico Erfo SpA's Receivables Turnover for the
six
months ended in Dec. 2025 was 4.05.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Laboratorio Farmaceutico Erfo SpA Receivables Turnover Related Terms
Laboratorio Farmaceutico Erfo SpA Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:ERFO vs KHC, GIS, HRL: Receivables Turnover Comparison
For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Farmaceutico Erfo SpA Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a Receivables Turnover of 4.05 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. According to the industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #863 out of 1946 companies in the Consumer Packaged Goods industry, placing it in the top 44.3%.
Is Laboratorio Farmaceutico Erfo SpA's Receivables Turnover too high?
Laboratorio Farmaceutico Erfo SpA's current Receivables Turnover is 4.05. The Consumer Packaged Goods industry median Receivables Turnover is 9.33. Laboratorio Farmaceutico Erfo SpA's value of 4.05 is 56.6% below this industry median. Based on the distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #863 out of 1946 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's Receivables Turnover compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #863 out of 1946 companies for Receivables Turnover. This puts Laboratorio Farmaceutico Erfo SpA in the upper half of its industry. The industry median Receivables Turnover is 9.33. Laboratorio Farmaceutico Erfo SpA's value of 4.05 is 56.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.33, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorio Farmaceutico Erfo SpA's current Receivables Turnover of 4.05 is 56.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Farmaceutico Erfo SpA's current Receivables Turnover is 4.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.12, compared to a current price of €1.20 — trading 43.4% below its estimated fair value. The current Receivables Turnover is 4.05 and 56.6% below the Consumer Packaged Goods industry median of 9.33. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current Receivables Turnover is 4.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued.
The current stock price of €1.20 is trading 43.4% below its estimated GF Value™ of €2.12.
GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.
Key valuation signals for MIL:ERFO:
Receivables Turnover: 4.05
GF Value™: €2.12 vs. price of €1.20 (43.4% below fair value)
Industry Position: 56.6% below the Consumer Packaged Goods median (#863 of 1946)
No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorio Farmaceutico Erfo SpA Business Description
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
66GF Score
Get the complete analysis for MIL:ERFO
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:ERFO has been successfully added to your 
